PHILADELPHIA, PA & BOSTON, MA — A new partnership between Thomas Jefferson University and Sempresto, Inc. is positioning a next-generation epinephrine autoinjector to reshape how millions of severe allergy patients ... Read more
Mychesco - Nov 16
(MedPage Today) -- ORLANDO -- Non-injection routes of epinephrine delivery are gaining proponents for rapid response to immunotherapy anaphylaxis in the allergists' office."I was pretty shocked the first time I used it," said Paul Ogershok... Read more
Medpagetoday - Nov 09
